Regadenoson
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06213 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 62 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | anaphylaxis | KG + DL |
| 2 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 3 | esotropia | KG + DL |
| 4 | pseudoallergy | KG + DL |
| 5 | headache disorder | KG + DL |
| 6 | migraine disorder | KG + DL |
| 7 | trigeminal autonomic cephalalgia | KG + DL |
| 8 | migraine with brainstem aura | KG + DL |
| 9 | glossodynia | KG + DL |
| 10 | coccygodynia | KG + DL |
| 11 | Raynaud disease | KG + DL |
| 12 | endobronchial leiomyoma | KG + DL |
| 13 | bronchus adenoma | KG + DL |
| 14 | endobronchial lipoma | KG + DL |
| 15 | atypical coarctation of aorta | KG + DL |
| 16 | scalp dermatosis | KG + DL |
| 17 | primary hereditary glaucoma | KG + DL |
| 18 | neuralgia | KG + DL |
| 19 | thrombotic disease | KG + DL |
| 20 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 21 | HER2 positive breast carcinoma | KG + DL |
| 22 | open-angle glaucoma | KG + DL |
| 23 | tendinitis | KG + DL |
| 24 | fibromyalgia | KG + DL |
| 25 | myositis fibrosa | KG + DL |
| 26 | idiopathic granulomatous myositis | KG + DL |
| 27 | disorder involving pain | KG + DL |
| 28 | aortic malformation | KG + DL |
| 29 | injury | KG + DL |
| 30 | cluster headache syndrome | KG + DL |
| 31 | autoimmune hemolytic anemia | KG + DL |
| 32 | pregnancy disorder with abortive outcome | KG + DL |
| 33 | sciatic neuropathy | KG + DL |
| 34 | hemicrania continua | KG + DL |
| 35 | exostosis | KG + DL |
| 36 | radiation or chemically induced disorder | KG + DL |
| 37 | postural orthostatic tachycardia syndrome | KG + DL |
| 38 | florid cemento-osseous dysplasia | KG + DL |
| 39 | perinatal disease | KG + DL |
| 40 | segmental odontomaxillary dysplasia | KG + DL |
| 41 | cell proliferation disorder | KG + DL |
| 42 | disease by subcellular system affected | KG + DL |
| 43 | progesterone-receptor negative breast cancer | KG + DL |
| 44 | breast tumor luminal A or B | KG + DL |
| 45 | progesterone-receptor positive breast cancer | KG + DL |
| 46 | normal breast-like subtype of breast carcinoma | KG + DL |
| 47 | obsolete vascular headache | KG + DL |
| 48 | migraine with or without aura, susceptibility to | KG + DL |
| 49 | regional odontodysplasia | KG + DL |
| 50 | obsolete rare pulmonary disease | KG + DL |
(Showing top 50 of 62 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.